Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly.
from US Top News and Analysis https://ift.tt/j3iVvQ9
Novo and Eli contender Zealand Pharma heralds its obesity drug alternative: It's our 'crown jewel'
October 10, 2024
0
